Axcelis reported GAAP gross margin of 47% and non-GAAP gross margin of 47.3% , above its outlook, driven by a higher mix of CS&I and a favorable mix of upgrades. Non-GAAP operating expenses were $62 million , above outlook due largely to higher variable compensation associated with better-than-expected performance. GAAP EPS was $1.10 and non-GAAP EPS was $1.49 .CFO Jamie Coogan added that fourth-quarter systems revenue was $156 million , while Customer Support & International (CS&I) revenue reached a quarte ...

Core Insights - Axcelis Technologies, Inc. will participate in SEMICON Japan 2025, showcasing its advanced ion implant technologies aimed at enhancing device performance and productivity while reducing cost of ownership [1][2][3] Company Overview - Axcelis has over 45 years of experience in providing innovative, high-productivity solutions for the semiconductor industry, focusing on ion implantation systems which are critical in the IC manufacturing process [4] Product Highlights - The Purion Power Series+ is optimized for next-generation power devices, including superjunction architectures, and includes various models for different energy applications [6] - The Purion H™ Series offers unmatched purity and precision with industry-leading productivity, featuring innovative scanned spot beam technology [6] - The Purion XE™ Series is recognized as the leading high energy implant platform, with the Purion XEmax model utilizing patented Boost Technology™ for advanced image sensor applications [6] - The GSD Ovation™ ES provides best-in-class high current hydrogen and helium implant capabilities, evolving from the industry benchmark GSD Ovation Series platform [6] Event Details - Axcelis will host a special event on December 18th at SEMICON Japan, providing an opportunity for attendees to meet the team and learn more about their technologies [3]